Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

361 та иш

Иш: Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers

  1. Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox

    Eugene V. Koonin, Jonathan S. Gootenberg, Omar O. Abudayyeh

    Шарҳ мақола20232 иқтибос
    ABI

  2. Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells

    Gils Roex, Diana Campillo-Davó, Donovan Flumens +6

    Мақола20222 иқтибос
    ABI

  3. Targeted Methylation and Gene Silencing of VEGF-A in Human Cells by Using a Designed Dnmt3a–Dnmt3L Single-Chain Fusion Protein with Increased DNA Methylation Activity

    Abu Nasar Siddique, Suneetha Nunna, Arumugam Rajavelu +7

    Мақола20122 иқтибос
    ABI

  4. Editing the epigenome: technologies for programmable transcription and epigenetic modulation

    Pratiksha I. Thakore, Joshua B. Black, Isaac B. Hilton +1

    Шарҳ мақола20162 иқтибос
    ABI

  5. Comparison of Cas9 activators in multiple species

    Alejandro Chavez, Marcelle Tuttle, Benjamin W. Pruitt +11

    Мақола20162 иқтибос
    ABI

  6. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

    Courtney D. DiNardo, Keith W. Pratz, Vinod Pullarkat +13

    Мақола20182 иқтибос
    ABI

  7. Search-and-replace genome editing without double-strand breaks or donor DNA

    Andrew V. Anzalone, Peyton B. Randolph, Jessie R. Davis +8

    Мақола20192 иқтибос
    ABI

  8. Expression and prognosis analysis of DNMT family in acute myeloid leukemia

    Ting‐juan Zhang, Liu-chao Zhang, Zi‐jun Xu +1

    Мақола20202 иқтибос
    ABI

  9. Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

    Mark Bustoros, Romanos Sklavenitis‐Pistofidis, Jihye Park +33

    Мақола20202 иқтибос
    ABI

  10. Ezh2 Inhibition by Tazemetostat: Mechanisms of Action, Safety and Efficacy in Relapsed/refractory Follicular Lymphoma

    Edith Julia, Gilles Salles

    Мақола20212 иқтибос
    ABI

  11. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study

    Yanlin Wu, Zhengjun Lin, Changchun Li +7

    Шарҳ мақола20232 иқтибос
    ABI

  12. Artificial intelligence and deep learning algorithms for epigenetic sequence analysis: A review for epigeneticists and AI experts

    Muhammad Tahir, Mahboobeh Norouzi, Shehroz S. Khan +3

    Шарҳ мақола20242 иқтибос
    ABI

  13. Epigenetics in the modern era of crop improvements

    Yan Xue, Xiaofeng Cao, Xiangsong Chen +52

    Шарҳ мақола20252 иқтибос
    ABI

  14. Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy

    Alireza Bayani, Munthar Kadhim Abosaoda, Jasur Rizaev +3

    Шарҳ мақолаAdvanced biosensing and bioanalysis techniquesClinical and Experimental Medicine20251 иқтибос
    ABI

  15. “Mesenchymal stem cell-derived exosomes (MSC-exosomes) in hematology: From mechanisms to clinical breakthroughs”

    Irfan Ahmad, Ahmed Hussein, Bhavesh Kanabar +8

    Шарҳ мақолаExtracellular vesicles in diseaseCellular Immunology20251 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI